PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations.

导出 OA

翻译打印收藏纠错

作者： Xin,Wang ^[1] ; Hua,Huang ^[2] ; Liangke,Zhang ^[1] ; Yan,Bai ^[2] ; Huali,Chen ^[1]

作者单位： a Department of pharmaceutics , School of Pharmacy, Chongqing Medical University , Chongqing , P. R. China and. ^[1] b Chongqing Research Center for Pharmaceutical Engineering , Chongqing , P. R. China. ^[2]

关键词 PCM TAT co-modified coumarin-6 myocardium delivery

主题词氨基酸序列(Amino Acid Sequence);动物(Animals);细胞存活(Cell Survival);细胞, 培养的(Cells, Cultured);药物释放系统(Drug Delivery Systems);药物评价, 临床前(Drug Evaluation, Preclinical);女(雌)性(Female);脂质体(Liposomes);男(雄)性(Male);小鼠(Mice);心肌(Myocardium);肽碎片(Peptide Fragments);随机分配(Random Allocation);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley)

DOI 10.1080/10717544.2016.1253121

PMID 28165817

发布时间 2024-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览9

Drug delivery

2017年24卷1期

339-345页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations.

Drug delivery

相似文献

Drug delivery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations.

Drug delivery

相似文献

Drug delivery

相关期刊

检索历史清除